Chemotherapy for Triple-Negative Breast Cancer: Is More Better?

被引：27

作者：

Mayer, Erica L. ^{[1
]}

Burstein, Harold J.

机构：

[1] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 28期

关键词：

PATHOLOGICAL COMPLETE RESPONSE; NEOADJUVANT CISPLATIN; DOSE-DENSE; FOLLOW-UP; TRIAL; CYCLOPHOSPHAMIDE; BEVACIZUMAB; CARBOPLATIN; DOXORUBICIN; BENEFIT;

D O I：

10.1200/JCO.2016.68.4068

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3369 / +

页数：4

共 20 条

[1] Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials [J].

Albain, K. ;

Anderson, S. ;

Arriagada, R. ;

Barlow, W. ;

Bergh, J. ;

Bliss, J. ;

Buyse, M. ;

Cameron, D. ;

Carrasco, E. ;

Clarke, M. ;

Correa, C. ;

Coates, A. ;

Collins, R. ;

Costantino, J. ;

Cutter, D. ;

Cuzick, J. ;

Darby, S. ;

Davidson, N. ;

Davies, C. ;

Davies, K. ;

Delmestri, A. ;

Di Leo, A. ;

Dowsett, M. ;

Elphinstone, P. ;

Evans, V. ;

Ewertz, M. ;

Gelber, R. ;

Gettins, L. ;

Geyer, C. ;

Goldhirsch, A. ;

Godwin, J. ;

Gray, R. ;

Gregory, C. ;

Hayes, D. ;

Hill, C. ;

Ingle, J. ;

Jakesz, R. ;

James, S. ;

Kaufmann, M. ;

Kerr, A. ;

MacKinnon, E. ;

McGale, P. ;

McHugh, T. ;

Norton, L. ;

Ohashi, Y. ;

Paik, S. ;

Pan, H. C. ;

Perez, E. ;

Peto, R. ;

Piccart, M. .

LANCET, 2012, 379 (9814) :432-444

[2]

[Anonymous], J CLIN ONCOL S

[3] Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial [J].

Bear, Harry D. ;

Tang, Gong ;

Rastogi, Priya ;

Geyer, Charles E., Jr. ;

Liu, Qing ;

Robidoux, Andre ;

Baez-Diaz, Luis ;

Brufsky, Adam M. ;

Mehta, Rita S. ;

Fehrenbacher, Louis ;

Young, James A. ;

Senecal, Francis M. ;

Gaur, Rakesh ;

Margolese, Richard G. ;

Adams, Paul T. ;

Gross, Howard M. ;

Costantino, Joseph P. ;

Paik, Soonmyung ;

Swain, Sandra M. ;

Mamounas, Eleftherios P. ;

Wolmark, Norman .

LANCET ONCOLOGY, 2015, 16 (09) :1037-1048

[4]

Blum JL, 2016, J CLIN ONCOL, V34

[5] Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients [J].

Byrski, T. ;

Huzarski, T. ;

Dent, R. ;

Marczyk, E. ;

Jasiowka, M. ;

Gronwald, J. ;

Jakubowicz, J. ;

Cybulski, C. ;

Wisniowski, R. ;

Godlewski, D. ;

Lubinski, J. ;

Narod, S. A. .

BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (02) :401-405

[6] Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741 [J].

Citron, ML ;

Berry, DA ;

Cirrincione, C ;

Hudis, C ;

Winer, EP ;

Gradishar, WJ ;

Davidson, NE ;

Martino, S ;

Livingston, R ;

Ingle, JN ;

Perez, EA ;

Carpenter, J ;

Hurd, D ;

Holland, JF ;

Smith, BL ;

Sartor, CI ;

Leung, EH ;

Abrams, J ;

Schilsky, RL ;

Muss, HB ;

Norton, L .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1431-1439

[7] Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00 [J].

Colleoni, Marco ;

Gray, Kathryn P. ;

Gelber, Shari ;

Lang, Istvan ;

Thurlimann, Beat ;

Gianni, Lorenzo ;

Abdi, Ehtesham A. ;

Gomez, Henry L. ;

Linderholm, Barbro K. ;

Puglisi, Fabio ;

Tondini, Carlo ;

Kralidis, Elena ;

Eniu, Alexandru ;

Cagossi, Katia ;

Rauch, Daniel ;

Chirgwin, Jacquie ;

Gelber, Richard D. ;

Regan, Meredith M. ;

Coates, Alan S. ;

Price, Karen N. ;

Viale, Giuseppe ;

Goldhirsch, Aron .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (28) :3400-+

[8] Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis [J].

Cortazar, Patricia ;

Zhang, Lijun ;

Untch, Michael ;

Mehta, Keyur ;

Costantino, Joseph P. ;

Wolmark, Norman ;

Bonnefoi, Herve ;

Cameron, David ;

Gianni, Luca ;

Valagussa, Pinuccia ;

Swain, Sandra M. ;

Prowell, Tatiana ;

Loibl, Sibylle ;

Wickerham, D. Lawrence ;

Bogaerts, Jan ;

Baselga, Jose ;

Perou, Charles ;

Blumenthal, Gideon ;

Blohmer, Jens ;

Mamounas, Eleftherios P. ;

Bergh, Jonas ;

Semiglazov, Vladimir ;

Justice, Robert ;

Eidtmann, Holger ;

Paik, Soonmyung ;

Piccart, Martine ;

Sridhara, Rajeshwari ;

Fasching, Peter A. ;

Slaets, Leen ;

Tang, Shenghui ;

Gerber, Bernd ;

Geyer, Charles E., Jr. ;

Pazdur, Richard ;

Ditsch, Nina ;

Rastogi, Priya ;

Eiermann, Wolfgang ;

von Minckwitz, Gunter .

LANCET, 2014, 384 (9938) :164-172

[9] Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy:: results of WSG AM-01 trial [J].

Gluz, O. ;

Nitz, U. A. ;

Harbeck, N. ;

Ting, E. ;

Kates, R. ;

Herr, A. ;

Lindemann, W. ;

Jackisch, C. ;

Berdel, W. E. ;

Kirchner, H. ;

Metzner, B. ;

Werner, F. ;

Schuett, G. ;

Frick, M. ;

Poremba, C. ;

Diallo-Danebrock, R. ;

Mohrmann, S. .

ANNALS OF ONCOLOGY, 2008, 19 (05) :861-870

[10] Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735 [J].

Jones, Stephen ;

Holmes, Frankie Ann ;

O'Shaughnessy, Joyce ;

Blum, Joanne L. ;

Vukelja, Svetislava J. ;

McIntyre, Kristi J. ;

Pippen, John E. ;

Bordelon, James H. ;

Kirby, Robert L. ;

Sandbach, John ;

Hyman, William J. ;

Richards, Donald A. ;

Mennel, Robert G. ;

Boehm, Kristi A. ;

Meyer, Wally G. ;

Asmar, Lina ;

Mackey, Daniel ;

Riedel, Stefan ;

Muss, Hyman ;

Savin, Michael A. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) :1177-1183

← 1 2 →